HOLD maintained at $353 with 10% defensive trim via hybrid trigger; add zone refined to $349-351 on structural support confirmation
HOLD is intellectually honest given intact structural quality (17.8% ROE, 42% efficiency, $33B buybacks, higher-for-longer NII tailwind) versus uncertain tactical setup (12 sessions sub-10 EMA/VWMA, MACD -0.98, third 50 SMA test) ahead of binary catalysts (CPI Friday, FOMC 9/17, Q3 earnings). Aggressive analyst's ADD fails four-binding-test (MACD -0.98, price below $355.90 for 12 sessions, price below $355.80 for 12 sessions, third 50 SMA test with negative momentum). Conservative analyst's stop tightening to $346 lacks confluence; Bollinger lower band $349.72 + 50 SMA $351.24 + Aug 21 swing low $350.37 form triple-confluence support. Neutral analyst's $349-351 add zone is realistic; trader's $333-343 zone rejected as too patient. Full Underweight blocked by unmet 8/21 and 9/2 binding lessons. Full Buy/Overweight blocked by unmet 8/14 (no executed hedge) and 8/25 four-technical caution rule. P/B 2.66x is above 1.8-2.5x historical range; NII decelerating from 33.8% to 3.1% sequential cadence; Q2 EPS $7.70 inflated ~21% by $4.39B special income item (normalized $6.10-6.20).
| Position | Action |
|---|---|
| Price rally to $360+ OR 3 trading sessions from now OR MACD histogram deterioration to -1.0 (whichever first) | Trim 10% via hybrid trigger |
| Price above $360 | Trim 25-30% to capture premium into strength and reduce concentration |
| Pullback to $349-351 with confirming volume >7M and positive MACD histogram turn | Add 7-8% incremental position size |
| Confirmed VWMA reclaim at $355.80 on volume with positive MACD histogram | Secondary add opportunity |
| Break and hold above $366 on heavy volume with MACD bullish re-cross | Upside add opportunity |
JPM is in the early innings of a multi-quarter NII re-acceleration driven by the higher-for-longer macro regime, with earnings power that holds even after stripping the special item, and valuation that remains below justified levels despite approaching $1T market cap.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 48.24 | neutral |
| MACD Line | +1.05 | bullish |
| MACD Signal | +2.03 | bullish |
| MACD Histogram | −0.98 | bearish |
| 50 SMA | $351.24 | neutral |
| 200 SMA | $317.19 | bullish |
| 10 EMA | $355.90 | bearish |
| VWMA (20) | $355.80 | bearish |
| Bollinger Upper Band | $364.44 | neutral |
| Bollinger Lower Band | $349.72 | neutral |
| ATR | $5.87 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Earnings power is real even after stripping special items — the franchise stands on fundamentals
↩ rebuts: “Bear claims Q2 2026 had a $4.39B special item that flattered results”
EV: Primary target: $366 (Aug 12 high); Secondary target: re-test of $380+ · concedes: UK windfall tax risk is real but discrete — UK earnings are a small fraction of the $186B TTM revenue; Bab el-Mandeb geopolitical tail risk: Sept 30 at 9%, Dec 31 at 22% — meaningful but not base case; oil-positive for trading desks is offsetting; Loan book up 36% in 3 years — provisions remain benign and no consumer stress signals yet; Dimon succession is a latent risk that's been latent for a decade and market has refused to discount; Bear's 'underlying EPS power may be closer to $6.10–$6.20 per quarter' estimate may be too conservative but still implies double-digit growth
The bull case is already priced in at current levels, and marginal data flow is deteriorating across technical, credit quality, and macro dimensions, creating asymmetric downside risk of 10-11% versus limited 3.5-11% upside.
EV: -$317 (bear case downside target, ~10-11% from current levels) · concedes: 93% no Fed cuts in 2026 and 59% ECB hike probability do extend NII runway near-term; Stripping out $4.39B, JPM still prints $16.75B in Q2; JPM is not a bad bank; it has strong structural franchise; 200 SMA at $317 represents firm trend-defining support; Bessent-vs-bond-market and Bab el-Mandeb are tail risks, not base case events
→ vs neutral: Technical analysis doesn't support the neutral view that technicals don't confirm; price holding 50 SMA with conviction after three tests with declining volume is textbook support confirmation, not a level about to break
→ vs conservative: The conservative 5-6% add-only-at-$333-$343 is a low-probability waiting game; stock already 6% above $333 and structural support at $349-$351 has held three times - waiting for $333 requires breaking triple-confluence support
→ vs neutral: Binary catalyst risk on CPI/FOMC is being overweighted; Polymarket at 93% no-cuts means hawkish positioning is already in the price, creating positive asymmetry where dovish surprises trigger relief rallies while hot prints are largely priced in
| neutral |
Support: 349.72 · 350.37 · 351.24 · 317.19 | Resistance: 355.9 · 357.62 · 364.44 · 366.09
JPM is in a healthy multi-month uptrend but undergoing near-term consolidation approximately 3.4% below the August 12 high of $366.09. The stock sits in a neutral zone: above the 200 SMA ($317.19) and 50 SMA ($351.24) but below the 10 EMA ($355.90) and VWMA ($355.80), suggesting mild distribution. The critical support cluster at $349.72–$351.24 (Bollinger lower band, 50 SMA, and August 21 low of $350.37) represents a triple confluence where buy-on-dip setups are preferred, while a sustained break below would warn of deeper mean reversion. Resistance clusters at $364.44–$366.09 mark the Bollinger upper band and August swing high as key supply zones. Tactical bias is neutral-to-cautiously bullish; the default stance is HOLD for existing positions with a recommendation to add on strength above $355.90 or on dips to the $349–$351 support zone.
Market Capitalization
$939.83 billion
Share Price (52W High / Low)
$366.50 / $279.10
50-Day Moving Average
$350.77
200-Day Moving Average
$318.87
P/E Ratio (TTM)
15.15x
Forward P/E
14.15x
PEG Ratio
1.67
Price to Book
2.66x
EPS (TTM)
$23.34
Forward EPS
$24.99
Dividend Yield
1.69%
Beta
0.975
Book Value / Share
$133.01
Total Revenue (TTM)
$186.3 billion
Net Income (TTM)
$63.6 billion
Q2 2026 Net Income
$21,155 million
Q2 2026 EPS
$7.70
Q2 2026 Net Interest Income
$25,511 million
2025 Total Revenue
$181,847 million
2025 Net Income
$57,048 million
2025 Diluted EPS
$20.02
2024 Total Revenue
$169,439 million
2024 Net Income
$58,471 million
2024 Diluted EPS
$19.75
Total Assets (Q2 2026)
$5,015,069 million
Total Assets (2025)
$4,424,900 million
Net Loans (Q2 2026)
$1,516,310 million
Common Stock Equity (Q2 2026)
$353,558 million
Tangible Book Value (Q2 2026)
$289,254 million
Net Debt (Q2 2026)
$223,142 million
CET1 (estimated)
15-16%
Net Profit Margin
34.92%
Return on Equity (ROE)
17.79%
Return on Assets (ROA)
1.36%
Efficiency Ratio
~42%
Trading Securities (Q2 2026)
$794,165 million
Q2 2026 Stock Repurchases
$8,788 million
Q2 2026 Dividends Paid
$4,342 million
Special Income Item (Q2 2026)
$4.39 billion
Annual Buyback Authorization
~$30 billion
Strengths
Concerns
JPM posted blowout Q2 2026 results with record EPS of $7.70 (+47% YoY) driven by accelerating Net Interest Income (+10% YoY to $25.5B) and a $4.39B special income reversal, though underlying earnings power may be closer to $6.10-6.20 per quarter absent the one-time item. The bank maintains best-in-class profitability metrics (17.79% ROE, 42% efficiency ratio, 34.9% net margin) with ~$50B annualized capital return, but valuation is full at P/B 2.66x near the 52-week high, and net debt tripled to $223B, creating funding cost exposure. Patient accumulation on pullbacks toward the 200-DMA (~$318-320) is recommended over chasing at current levels.
Macro: Hawkish-risk-off regime with sticky/re-accelerating inflation (hot PPI print; CPI due), Treasury yields surging despite administration jawboning (AI corporate bond supply at 68% of Treasury issuance creating duration supply), and geopolitical escalation around Iran/Red Sea (Bab el-Mandeb closure odds rising sharply: Sept 30 at 9%, Oct 31 at 19%, Dec 31 at 22%). Global central banks pivoting hawkish: Fed zero cuts priced at 93% for 2026; ECB October 25 bps hike at 59% (+45.5pp week). US recession probability remains low at 8%. Risk assets de-risked pre-CPI with S&P breaking technical support, copper and FCX sold off on tariff/yield combo.